Position in REGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,446,463
-$535,519 QoQ
Shares Held
7,131
+10.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#403
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026COMMERCE BANK holds $32,396,174 across 26 Biotechnology names. REGN ranks #1 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
7,131 | $4,446,463 | |
| 2 | EXEL |
Exelixis, Inc.
|
78,937 | $4,294,961 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,033 | $3,990,231 | |
| 4 | MRNA |
Moderna, Inc.
|
55,243 | $3,868,667 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,461 | $2,848,043 | |
| 6 | TECH |
BIO-TECHNE Corp
|
33,609 | $2,374,475 | |
| 7 | INCY |
Incyte Corp
|
20,084 | $2,276,721 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
17,206 | $1,346,712 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,446,463 | 7,131 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,981,982 | 6,448 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,839,624 | 6,270 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,491,696 | 6,210 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,230,325 | 6,153 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $4,298,810 | 6,778 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $4,846,692 | 6,804 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $7,059,075 | 6,715 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $7,125,982 | 6,780 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $6,011,711 | 6,246 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $5,460,328 | 6,217 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $4,904,840 | 5,960 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,288,964 | 5,969 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $4,827,311 | 5,875 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $4,201,957 | 5,824 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $4,036,777 | 5,860 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $3,677,419 | 6,221 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,356,743 | 6,238 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $4,531,787 | 7,176 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,148,990 | 11,813 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $4,924,646 | 8,817 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $4,387,899 | 9,274 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $4,481,328 | 9,276 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $5,128,144 | 9,161 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $6,438,561 | 10,324 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $3,803,778 | 7,790 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||